Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06519


Purpose:

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.


Criteria:

Inclusion Criteria: - DSM-IV diagnosis of bipolar disorder - Presence of a current major depressive episode on the SCID - Score of 17 or great on the HDRS - Capable of giving voluntary written consent Exclusion Criteria: - Significant current substance dependence/abuse within 3 months preceding the trial - Active suicidal ideation - Pregnant/lactating mothers - Significant medical history


NCT ID:

NCT00566150


Primary Contact:

Principal Investigator
Zubin Bhagwagar, MD PhD
Yale University

Kathleen Maloney, BA
Phone: 203-974-7496
Email: kathleen.maloney@yale.edu


Backup Contact:

Email: jason.chen.jc64@yale.edu
Jason Chen, BA
Phone: 203-974-7559


Location Contact:

New Haven, Connecticut 06519
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.